Yervoy
Yervoy is a brand name for an immunotherapy drug developed by Bristol Myers Squibb. It is a checkpoint inhibitor, specifically a programmed cell death protein 1 (PD-1) blocking antibody. Yervoy works by helping the immune system recognize and attack cancer cells. It does this by targeting and blocking the PD-1 receptor, which is found on T-cells, a type of immune cell. Cancer cells can use PD-1 to evade detection by the immune system. By blocking PD-1, Yervoy can unleash the immune system's ability to fight the cancer.
Yervoy is primarily used in the treatment of advanced melanoma, a type of skin cancer. It is